Replies to post #102955 on Cytodyn Inc (CYDY)

[gimmeshelter]

You're right, if all you seek for proof is pure clinical trial results in efficacy. That's coming in the next two weeks and some subtle indicators suggest it will be good, like the financing deal at $10/share, mgmt enthusiasm, etc. The concerted effort at hit pieces to counter good news events looks like some profiteers are nervous about the potential here. The closest measure to trial results go on is the e-ind treatments that saved numerous lives and reduced viral load in everyone treated, all in sever cases, until FDA ordered them to stop and proceed with clinical trials. Excellent safety data will likely help efficacy results in that it allows patients to continue treatment when more toxic treatments like Remdesivir or the steroid in the UK have to be stopped due to SAE. LL doesn't have that issue. Lots of promise here, we'll get our first real efficacy data soon.

[LongTkt]

Serious Justdafacts question.

I think I understand your contrarian role on this forum to balance the posters who cannot even begin to entertain negative CYDY points of view. But maybe this is a dumb question for me to ask.

What type of publication or news would it take for you to have a positive outlook on CYDY specifically as a COVID treatment?

If you are waiting until an FDA approval to mitigate the majority of investment risk in CYDY, then your SP entry point is going to be very expensive.